Importer of Controlled Substances Registration, 52908 [2016-18922]

Download as PDF 52908 Federal Register / Vol. 81, No. 154 / Wednesday, August 10, 2016 / Notices replace the volume of articles potentially subject to the recommended orders within a commercially reasonable time; and (v) explain how the recommended orders would impact consumers in the United States. Written submissions must be filed no later than by close of business on September 6, 2016. Persons filing written submissions must file the original document electronically on or before the deadlines stated above and submit 8 true paper copies to the Office of the Secretary by noon the next day pursuant to Commission Rule 210.4(f), 19 CFR 210.4(f). Submissions should refer to the investigation number (‘‘Inv. No. 947’’) in a prominent place on the cover page and/or the first page. (See Handbook for Electronic Filing Procedures, http:// www.usitc.gov/secretary/fed_reg_ notices/rules/handbook_on_electronic_ filing.pdf). Persons with questions regarding filing should contact the Secretary, (202) 205–2000. Any person desiring to submit a document to the Commission in confidence must request confidential treatment. All such requests should be directed to the Secretary to the Commission and must include a full statement of the reasons why the Commission should grant such treatment. See 19 CFR 201.6. Documents for which confidential treatment by the Commission is properly sought will be treated accordingly. All information, including confidential business information and documents for which confidential treatment is properly sought, submitted to the Commission for purposes of this Investigation may be disclosed to and used: (i) By the Commission, its employees and Offices, and contract personnel (a) for developing or maintaining the records of this or a related proceeding, or (b) in internal investigations, audits, reviews, and evaluations relating to the programs, personnel, and operations of the Commission including under 5 U.S.C. Appendix 3; or (ii) by U.S. government employees and contract personnel, solely for cybersecurity purposes. All contract personnel will sign appropriate nondisclosure agreements. All non-confidential written submissions will be available for public inspection at the Office of the Secretary and on EDIS. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). Company mstockstill on DSK3G9T082PROD with NOTICES The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company’s maintenance of effective controls against diversion by inspecting and testing each company’s physical security systems, verifying each company’s compliance with state and local laws, and reviewing each company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance 17:34 Aug 09, 2016 Jkt 238001 [FR Doc. 2016–18904 Filed 8–9–16; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Importer of Controlled Substances Registration ACTION: Notice of registration. Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances. SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUMMARY: FR Docket Mylan Pharmaceuticals, Inc. ................................................... Hospira .................................................................................... Cambrex Charles City ............................................................ Pharmacore ............................................................................ Mallinckrodt LLC ..................................................................... Meda Pharmaceuticals, Inc. ................................................... Stepan Company .................................................................... VerDate Sep<11>2014 By order of the Commission. Issued: August 4, 2016. Lisa R. Barton, Secretary to the Commission. 80 81 81 81 81 81 81 FR FR FR FR FR FR FR Published 75691 .......................................................................... 1208 ............................................................................ 14892 .......................................................................... 15565 .......................................................................... 15566 .......................................................................... 15560 .......................................................................... 20417 .......................................................................... with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons. Dated: August 2, 2016. Louis J. Milione, Deputy Assistant Administrator. Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances. SUMMARY: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices. SUPPLEMENTARY INFORMATION: [FR Doc. 2016–18922 Filed 8–9–16; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Bulk Manufacturer of Controlled Substances Registration ACTION: PO 00000 Notice of registration. Frm 00099 Fmt 4703 Sfmt 4703 December 3, 2015. January 11, 2016. March 18, 2016. March 23, 2016. March 23, 2016. March 23, 2016. April 7, 2016 E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 81, Number 154 (Wednesday, August 10, 2016)]
[Notices]
[Page 52908]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18922]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Registrants listed below have applied for and been granted 
registration by-the Drug Enforcement Administration (DEA) as importers 
of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as an importer of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

------------------------------------------------------------------------
           Company                FR Docket             Published
------------------------------------------------------------------------
Mylan Pharmaceuticals, Inc...  80 FR 75691....  December 3, 2015.
Hospira......................  81 FR 1208.....  January 11, 2016.
Cambrex Charles City.........  81 FR 14892....  March 18, 2016.
Pharmacore...................  81 FR 15565....  March 23, 2016.
Mallinckrodt LLC.............  81 FR 15566....  March 23, 2016.
Meda Pharmaceuticals, Inc....  81 FR 15560....  March 23, 2016.
Stepan Company...............  81 FR 20417....  April 7, 2016
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each company's 
maintenance of effective controls against diversion by inspecting and 
testing each company's physical security systems, verifying each 
company's compliance with state and local laws, and reviewing each 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or II controlled substances to the above 
listed persons.

    Dated: August 2, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-18922 Filed 8-9-16; 8:45 am]
 BILLING CODE 4410-09-P